Traws Pharma, Inc. (TRAW) › Operating IncomeTraws Pharma, Inc. (TRAW) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$27.57M2012: -$22.28M2013: -$62.22M2014: -$63.74M2015: -$23.97M2016: -$23.70M2017: -$25.74M2018: -$23.28M2019: -$21.70M2020: -$24.99M2021: -$16.50M2022: -$19.63M2023: -$20.30M2024: -$142.37M2025: -$17.88M-$17.88M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$17.88M+87.4%2024-$142.37M-601.4%2023-$20.30M-3.4%2022-$19.63M-19.0%2021-$16.50M+34.0%2020-$24.99M-15.2%2019-$21.70M+6.8%2018-$23.28M+9.5%2017-$25.74M-8.6%2016-$23.70M+1.1%2015-$23.97M+62.4%2014-$63.74M-2.4%2013-$62.22M-179.3%2012-$22.28M+19.2%2011-$27.57M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share